ABMR samples showed significant upregulation of OXPHOS, pentose phosphate pathway, riboflavin metabolism, N-Glycan biosynthesis, glycolysis/gluconeogenesis, citrate cycle (TCA cycle), pyrimidine metabolism, fructose and mannose metabolism, glycosaminoglycan degradation, and other glycan degradation
Regulatory status (as of publication): Not approved by the FDA, EMA, or any other regulatory authority for any indication
Understanding each option helps inform discussions with healthcare providers
Given as a subcutaneous injection, near the area of interest for localized effects or in the abdomen for systemic goals (gut, general recovery)
The standards and test samples are added into the wells and the Glutathione S Transferase mu present in each sample is bound to the wells by the immobilized antibody